health partners glp 1 coverage Patients Face New Barriers for GLP-1 Drugs Trusted Weight Loss Clinic Serving

Novo Nordisk's semaglutide beats its counterpart liraglutide to become the next generation of weight loss innovation, and then Eli Lilly's GLP-1R/GIPR dual-target agonist tirzepatide achieves a 22.5% weight loss, surpassing semaglutide's weight loss history

For 40+ years, my work and that of others supported the view that addiction is a disorder of maladaptive dopaminergic learning

Catalano PM, Farrell K, Thomas A, Huston-Presley L, Mencin P, de Mouzon SH, et al

but the midrange was fuller with more bloom, perhaps deeper in the stage, and the top end was slightly less pristine

Dr Paula Diab gives an overview of GLP-1 drugs, their approved uses, and who might benefit the most

The drugmakers that make Zepbound and Wegovy sell the medicines at a discount to people who pay out of pocket instead of using insurance